The expression of NF-κB is increased in FGF21 knockdown hepatocytes and promotes the progression of NASH to HCC through the axis of Toll-like receptor 4 (TLR4)/NF-κB/IL-17A axis) [20]. Here, FGF21 is linked to metabolic dysfunction-associated steatohepatitis.